Urofollitropin For Human Medicines

In human fertility drug development, Urofollitropin is often selected not only for its follicle-stimulating activity, but also for its predictable behavior during formulation and quality testing. For manufacturers, the real challenge lies in maintaining batch-to-batch consistency while meeting internal release standards and regulatory expectations.

This FSH API is supplied as a raw material for further pharmaceutical processing. It is intended for professional use in controlled manufacturing environments rather than direct clinical application.

Key Technical Parameters

 

Product Name: Urofollitropin API

Category: Human protein & peptide active ingredient

Physical Form: Lyophilized powder, white to off-white

Activity Expression: International Units (IU), batch specific

Solubility: Suitable for sterile aqueous reconstitution

Storage Recommendation:

- Short-term: 2–8 °C

- Long-term: −20 °C

- Protect from light and moisture

Each production lot is accompanied by full analytical documentation to support internal QA review.

Batch Control and Release Logic

 

Unlike many small-molecule APIs, peptide hormones such as Urofollitropin require activity-focused evaluation. Release is therefore based on a combination of:

•  
• Verified biological activity values
• Controlled impurity profile within defined internal limits
• Visual and physical inspection of the lyophilized cake

This approach allows pharmaceutical buyers to align incoming material with existing in-house standards, reducing additional qualification workload.

How Manufacturers Typically Use This API

 

Most clients integrate Urofollitropin API at the early formulation or scale-up stage of injectable fertility products. Common internal workflows include:

• Small-scale reconstitution testing to confirm clarity and recovery
• Compatibility assessment with stabilizers or excipients
• Stability observation under accelerated and real-time conditions

To support these steps, sample orders are available before moving into long-term bulk supply arrangements.

Packaging, Logistics, and Traceability

 

• Packaging Options: Multiple vial sizes available for laboratory or production use
• Transport: Standard cold-chain logistics on request
• Traceability: Clear batch number and production record linkage for audit readiness

Packaging formats are designed to integrate smoothly into pharmaceutical warehousing and material management systems.

Procurement Advantages

 

• Flexible MOQ to support early-stage evaluation
• Scalable bulk supply for commercial production planning
• Stable sourcing strategy suitable for long-term programs
• Documentation package aligned with pharmaceutical QA requirements

This structure helps procurement teams balance cost control with supply reliability.

Frequently Asked Questions

 

Q: Is this product supplied as a finished injectable?

A: No. Urofollitropin is provided strictly as an API for further formulation.

Q: What documents are included?

A: COA, MSDS/TDS, and batch-specific analytical data are supplied with each order.

Q: Can the material be used for pilot batches?

A: Yes. Many customers begin with sample orders for pilot-scale validation.

Q: Is OEM packaging available?

A: Custom packaging and labeling can be discussed based on project needs.